Skip to main content
See every side of every news story
Published loading...Updated

Biodesix expects 2026 sales to crack $100M

Summary by Daily Camera
LOUISVILLE — Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, improved its top and bottom lines in both the fourth quarter of last year and the full 2025 fiscal year. The company posted total sales of $28.8 million in the most-recent period, good for a 41% year-over-year bump, and $88.5 million in fiscal 2025, an increase of 24%. Biodesix’s net loss in the fourth quarter was $4 mi…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Daily Camera broke the news in Boulder, United States on Wednesday, March 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal